{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:10:17Z","timestamp":1750306217286,"version":"3.41.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473112","82372772"],"award-info":[{"award-number":["82473112","82372772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Shandong Province of China","award":["ZR2024MH011"],"award-info":[{"award-number":["ZR2024MH011"]}]},{"name":"Youth Innovation Science and Technology Program of Shandong Provincial Universities","award":["2023KJ018","2022KJ187"],"award-info":[{"award-number":["2023KJ018","2022KJ187"]}]},{"name":"Special Foundation for Taishan Scholars Program of Shandong Province","award":["No. tsqn202306373"],"award-info":[{"award-number":["No. tsqn202306373"]}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["No.2021CXGC011104"],"award-info":[{"award-number":["No.2021CXGC011104"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Diffuse-type gastric cancer (DGC) accounts for approximately one-third of gastric cancer cases, but it is clinically more aggressive and associated with poorer survival prognosis compared to intestinal-type gastric cancer (IGC). Our study revealed significantly reduced ESRP1 expression in DGC patients relative to IGC counterparts, with its high expression positively correlating with DGC patient prognosis. Both in vitro and in vivo experimental models demonstrated that ESRP1 has the ability to hinder the malignant progression of DGC. Mechanistically, ESRP1 interacts with DHCR7, a ferroptosis-promoting regulator, thereby upregulating DHCR7 expression and enhancing ferroptosis susceptibility in DGC cells. In DGC patients with high ESRP1 expression, ferroptosis-inducing therapy emerges as a promising treatment alternative. Moreover, for ESRP1-low DGC cases, we identified several potent small-molecule drugs. These findings collectively position ESRP1 as a potential therapeutic target for DGC intervention.<\/jats:p>","DOI":"10.1186\/s13046-025-03435-2","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T02:33:15Z","timestamp":1750213995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ESRP1 exerts anti-tumor role by promoting ferroptosis in diffuse-type gastric cancer"],"prefix":"10.1186","volume":"44","author":[{"given":"Kang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaodong","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoshan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1074-8595","authenticated-orcid":false,"given":"Wei","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"issue":"3","key":"3435_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"0365\u20135555 Print","key":"3435_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and So-Called Intestinal-Type carcinoma. An attempt at a Histo-Clinical classification. Acta Pathologica Et Microbiol Scand. 1965;64(0365\u20135555 Print):31\u201349.","journal-title":"Acta Pathologica Et Microbiol Scand"},{"key":"3435_CR3","doi-asserted-by":"crossref","unstructured":"Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse gastric cancer: A summary of analogous contributing factors for its molecular pathogenicity. Int J Mol Sci. 2018; 19(8):2424.","DOI":"10.3390\/ijms19082424"},{"key":"3435_CR4","doi-asserted-by":"crossref","unstructured":"van der Kaaij RT, Koemans WJ, van Putten M, Snaebjornsson P, Luijten J, van Dieren JM, Cats A, Lemmens V, Verhoeven RHA, van Sandick JW. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015. Eur J Cancer (Oxford, England: 1990). 2020; 130:23\u201331.","DOI":"10.1016\/j.ejca.2020.02.017"},{"issue":"6","key":"3435_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11523-024-01097-2","volume":"19","author":"LW Wu","year":"2024","unstructured":"Wu LW, Jang SJ, Shapiro C, Fazlollahi L, Wang TC, Ryeom SW, Moy RH. Diffuse gastric cancer: A comprehensive review of molecular features and emerging therapeutics. Target Oncol. 2024;19(6):845\u201365.","journal-title":"Target Oncol"},{"issue":"1","key":"3435_CR6","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41467-018-03121-2","volume":"9","author":"S Ge","year":"2018","unstructured":"Ge S, Xia X, Ding C, Zhen B, Zhou Q, Feng J, Yuan J, Chen R, Li Y, Ge Z, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9(1):1012.","journal-title":"Nat Commun"},{"issue":"8","key":"3435_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc1141","volume":"3","author":"Y Yuasa","year":"2003","unstructured":"Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 2003;3(8):592\u2013600.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"3435_CR8","doi-asserted-by":"publisher","first-page":"188719","DOI":"10.1016\/j.bbcan.2022.188719","volume":"1877","author":"JL Monster","year":"2022","unstructured":"Monster JL, Kemp LJS, Gloerich M, van der Post RS. Diffuse gastric cancer: emerging mechanisms of tumor initiation and progression. Biochim Et Biophys Acta Reviews cancer. 2022;1877(3):188719.","journal-title":"Biochim Et Biophys Acta Reviews cancer"},{"issue":"11","key":"3435_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41388-023-02599-5","volume":"42","author":"AM Minikes","year":"2023","unstructured":"Minikes AM, Song Y, Feng Y, Yoon C, Yoon SS, Jiang X. E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene. 2023;42(11):848\u201357.","journal-title":"Oncogene"},{"issue":"1","key":"3435_CR10","doi-asserted-by":"publisher","first-page":"188549","DOI":"10.1016\/j.bbcan.2021.188549","volume":"1876","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhu X, Wei X, Tang C, Zhang W. HER2-targeted therapies in gastric cancer. Biochim Et Biophys Acta Reviews cancer. 2021;1876(1):188549.","journal-title":"Biochim Et Biophys Acta Reviews cancer"},{"issue":"Pt 3","key":"3435_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","volume":"86","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Sem Cancer Biol. 2022;86(Pt 3):566\u201382.","journal-title":"Sem Cancer Biol"},{"issue":"1","key":"3435_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-017-0473-4","volume":"10","author":"P Singh","year":"2017","unstructured":"Singh P, Toom S, Huang Y. Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer. J Hematol Oncol. 2017;10(1):105.","journal-title":"J Hematol Oncol"},{"issue":"19","key":"3435_CR13","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1038\/emboj.2010.195","volume":"29","author":"CC Warzecha","year":"2010","unstructured":"Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, Guo W, Xing Y, Carstens RP. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J. 2010;29(19):3286\u2013300.","journal-title":"EMBO J"},{"issue":"5","key":"3435_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2009.01.025","volume":"33","author":"CC Warzecha","year":"2009","unstructured":"Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell. 2009;33(5):591\u2013601.","journal-title":"Mol Cell"},{"issue":"1","key":"3435_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12935-023-03180-6","volume":"23","author":"KM Jeong","year":"2023","unstructured":"Jeong KM. Role of epithelial splicing regulatory protein 1 in cancer progression. Cancer Cell Int. 2023;23(1):331\u2013331.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"3435_CR16","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1038\/oncsis.2017.87","volume":"6","author":"HM Jeong","year":"2017","unstructured":"Jeong HM, Han J, Lee SH, Park HJ, Lee HJ, Choi JS, Lee YM, Choi YL, Shin YK, Kwon MJ. ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cellsthis Article has been corrected since advance online publication and an erratum is also printed in this issue. Oncogenesis. 2017;6(10):e389\u2013389.","journal-title":"Oncogenesis"},{"key":"3435_CR17","doi-asserted-by":"crossref","unstructured":"G\u00f6kmen-Polar Y, Neelamraju Y, Goswami CP, Gu Y, Gu X, Nallamothu G, Vieth E, Janga SC, Ryan M, Badve SS. Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways. EMBO Rep. 2019; 20(2):e46078","DOI":"10.15252\/embr.201846078"},{"key":"3435_CR18","doi-asserted-by":"publisher","first-page":"556650","DOI":"10.3389\/fonc.2020.556650","volume":"10","author":"LH Ho","year":"2020","unstructured":"Lee HH, Lee AJ, Park WS, Lee J, Park J, Park B, Joung JY, Lee KH, Hong D, Kim SH. Epithelial splicing regulatory protein (ESPR1) expression in an unfavorable prognostic factor in prostate Cancer patients. Front Oncol. 2020;10:556650\u2013556650.","journal-title":"Front Oncol"},{"key":"3435_CR19","doi-asserted-by":"crossref","unstructured":"Marta M, Ugo A, Daniela C, Emanuela T, Enzo M, Fiorella A, Sharmila F. The RNA-Binding protein ESRP1 modulates the expression of RAC1b in colorectal Cancer cells. Cancers.2021, 13(16):4092\u20134092.","DOI":"10.3390\/cancers13164092"},{"issue":"7","key":"3435_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41419-020-2706-7","volume":"11","author":"Q Tongyuan","year":"2020","unstructured":"Qu T, Zhang W, Qi L, Cao L, Liu C, Huang Q, Li G, Li L, Wang Y, Guo Q, et al. ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression. Cell Death Dis. 2020;11(7):511.","journal-title":"Cell Death Dis"},{"key":"3435_CR21","doi-asserted-by":"crossref","unstructured":"Teles SP, Oliveira P, Ferreira M, Carvalho J, Ferreira P, Oliveira C. Integrated analysis of structural variation and RNA expression of FGFR2 and its splicing modulator ESRP1 highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in diffuse gastric Cancer. Cancers. 2019;12(1):70\u201370.","DOI":"10.3390\/cancers12010070"},{"issue":"1","key":"3435_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41420-023-01757-8","volume":"9","author":"L Chengguo","year":"2023","unstructured":"Li C, Yin Y, Tao R, Lin Y, Wang T, Shen Q, Li R, Tao K, Liu W. ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer. Cell Death Discovery. 2023;9(1):464\u2013464.","journal-title":"Cell Death Discovery"},{"issue":"3","key":"3435_CR23","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.18632\/aging.202295","volume":"13","author":"Z Meng","year":"2021","unstructured":"Zheng M, Niu Y, Bu J, Liang S, Zhang Z, Liu J, Guo L, Zhang Z, Wang Q. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-\u03b2\/Smad signaling. Aging. 2021;13(3):3554\u201372.","journal-title":"Aging"},{"key":"3435_CR24","doi-asserted-by":"crossref","unstructured":"Yu S, Wang M, Zhang H, Guo X, Qin R. Circ_0092367 inhibits EMT and gemcitabine resistance in pancreatic Cancer via regulating the miR-1206\/ESRP1 Axis. Genes. 2021; 12(11):1701.","DOI":"10.3390\/genes12111701"},{"issue":"5","key":"3435_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an Iron-Dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"1","key":"3435_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","volume":"43","author":"Y Hua","year":"2024","unstructured":"Hua Y, Yang S, Zhang Y, Li J, Wang M, Yeerkenbieke P, Liao Q, Liu Q. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment. J Experimental Clin cancer Research: CR. 2024;43(1):19.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"7545","key":"3435_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"J Le","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362.","journal-title":"Nature"},{"issue":"2","key":"3435_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"L Guang","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H, Gan B.The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30(2):146\u201362.","journal-title":"Cell Res"},{"issue":"4","key":"3435_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334.","journal-title":"Cancer Cell"},{"issue":"5","key":"3435_CR30","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ. 2022;29(5):895\u2013910.","journal-title":"Cell Death Differ"},{"issue":"7545","key":"3435_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362.","journal-title":"Nature"},{"issue":"9","key":"3435_CR32","doi-asserted-by":"publisher","first-page":"113110","DOI":"10.1016\/j.celrep.2023.113110","volume":"42","author":"S Lei","year":"2023","unstructured":"Lei S, Chen C, Han F, Deng J, Huang D, Qian L, Zhu M, Ma X, Lai M, Xu E, et al. AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11- and FTL-mediated ferroptosis. Cell Rep. 2023;42(9):113110.","journal-title":"Cell Rep"},{"issue":"7","key":"3435_CR33","doi-asserted-by":"publisher","first-page":"114424","DOI":"10.1016\/j.celrep.2024.114424","volume":"43","author":"H Chen","year":"2024","unstructured":"Chen H, Jing C, Shang L, Zhu X, Zhang R, Liu Y, Wang M, Xu K, Ma T, Jing H, et al. Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer. Cell Rep. 2024;43(7):114424.","journal-title":"Cell Rep"},{"key":"3435_CR34","doi-asserted-by":"crossref","unstructured":"Chong W, Ren H, Chen H, Xu K, Zhu X, Liu Y, Sang Y, Li H, Liu J, Ye C, et al.Clinical features and molecular landscape of cuproptosis signature-related molecular subtype in gastric cancer. iMeta. 2024; 3(3):e190-e190.","DOI":"10.1002\/imt2.190"},{"issue":"11","key":"3435_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"M Anand","year":"2018","unstructured":"Anand M, De-Chen L, Yassen A, Christoph P, Phillip KH. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"key":"3435_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3389\/fimmu.2019.01113","volume":"10","author":"H Chen","year":"2019","unstructured":"Chen H, Chong W, Wu Q, Yao Y, Mao M, Wang X. Association of LRP1B mutation with tumor mutation burden and outcomes in melanoma and Non-small cell lung Cancer patients treated with immune Check-Point Blockades. Front Immunol. 2019;10:1113.","journal-title":"Front Immunol"},{"key":"3435_CR37","doi-asserted-by":"crossref","unstructured":"Chen H, Zhang T, Zhang Y, Wu H, Fang Z, Liu Y, Chen Y, Wang Z, Jia S, Ji X, et al. Deciphering the tumor microenvironment cell-infiltrating landscape reveals microenvironment subtypes and therapeutic potentials for nonsquamous NSCLC. JCI Insight. 2022; 7(12):e152815.","DOI":"10.1172\/jci.insight.152815"},{"issue":"8","key":"3435_CR38","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1111\/cas.14113","volume":"110","author":"H Chen","year":"2019","unstructured":"Chen H, Chong W, Teng C, Yao Y, Wang X, Li X. The immune response-related mutational signatures and driver genes in non-small-cell lung cancer. Cancer Sci. 2019;110(8):2348\u201356.","journal-title":"Cancer Sci"},{"issue":"1","key":"3435_CR39","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1038\/s41467-022-32627-z","volume":"13","author":"K Sun","year":"2022","unstructured":"Sun K, Xu R, Ma F, Yang N, Li Y, Sun X, Jin P, Kang W, Jia L, Xiong J, et al. scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory. Nat Commun. 2022;13(1):4943.","journal-title":"Nat Commun"},{"issue":"12","key":"3435_CR40","doi-asserted-by":"publisher","first-page":"100910","DOI":"10.1016\/j.crmeth.2024.100910","volume":"4","author":"D Zeng","year":"2024","unstructured":"Zeng D, Fang Y, Qiu W, Luo P, Wang S, Shen R, Gu W, Huang X, Mao Q, Wang G, et al. Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR 2.0. Cell Rep Methods. 2024;4(12):100910.","journal-title":"Cell Rep Methods"},{"issue":"11","key":"3435_CR41","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.7150\/thno.73089","volume":"12","author":"C Wei","year":"2022","unstructured":"Chong W, Zhu X, Ren H, Ye C, Xu K, Wang Z, Jia S, Shang L, Li L, Chen H. Integrated multi-omics characterization of KRAS mutant colorectal cancer. Theranostics. 2022;12(11):5138\u201354.","journal-title":"Theranostics"},{"issue":"4","key":"3435_CR42","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3892\/ol.2014.1849","volume":"7","author":"KJ Un","year":"2014","unstructured":"Un KJ. Chromosome 8q as the most frequent target for amplification in early gastric carcinoma. Oncol Lett. 2014;7(4):1139\u201343.","journal-title":"Oncol Lett"},{"issue":"6","key":"3435_CR43","first-page":"683","volume":"11","author":"K Masuko","year":"2003","unstructured":"Masuko K, Masaru K. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med. 2003;11(6):683\u20139.","journal-title":"Int J Mol Med"},{"issue":"7","key":"3435_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"L Guang","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"3435_CR45","doi-asserted-by":"crossref","unstructured":"Gan B. Mitochondrial regulation of ferroptosis. J Cell Biol. 2021, 220(9):e202105043.","DOI":"10.1083\/jcb.202105043"},{"key":"3435_CR46","doi-asserted-by":"crossref","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK,et al. CD8\u2009+\u2009T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 2022, 40(4):365-78.e6.","DOI":"10.1016\/j.ccell.2022.02.003"},{"issue":"1","key":"3435_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Yang W, Zheng Y, Dai W, Ji J, Wu L, Cheng Z, Zhang J, Li J, Xu X, et al. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to Sorafenib via ferroptosis. J Experimental Clin cancer Research: CR. 2023;42(1):6.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"8","key":"3435_CR48","doi-asserted-by":"publisher","first-page":"e1002218","DOI":"10.1371\/journal.pgen.1002218","volume":"7","author":"IM Shapiro","year":"2011","unstructured":"Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB, Gertler FB. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 2011;7(8):e1002218.","journal-title":"PLoS Genet"},{"issue":"12","key":"3435_CR49","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1158\/1541-7786.MCR-10-0568","volume":"9","author":"Y Dianbo","year":"2011","unstructured":"Yao D, Dai C, Peng S. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol cancer Research: MCR. 2011;9(12):1608\u201320.","journal-title":"Mol cancer Research: MCR"},{"issue":"36","key":"3435_CR50","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1038\/onc.2013.392","volume":"33","author":"JUYM K","year":"2014","unstructured":"Ueda J, Matsuda Y, Yamahatsu K, Uchida E, Naito Z, Korc M, Ishiwata T.Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases. Oncogene. 2014;33(36):4485\u201395.","journal-title":"Oncogene"},{"issue":"15","key":"3435_CR51","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/ijms20153705","volume":"20","author":"Z-H Chen","year":"2019","unstructured":"Chen ZH, Jing YJ, Yu JB, Jin ZS, Li Z, He TT, Su XZ. ESRP1 induces cervical Cancer cell G1-Phase arrest via regulating Cyclin A2 mRNAstability. Int J Mol Sci. 2019;20(15):3705\u20133705.","journal-title":"Stab International J Mol Sciences"},{"issue":"2","key":"3435_CR52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1158\/1541-7786.MCR-14-0366","volume":"13","author":"L Zhi-xiang","year":"2015","unstructured":"Lu ZX, Huang Q, Park JW, Shen S, Lin L, Tokheim CJ, Henry MD, Xing Y. Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization. Mol cancer Research: MCR. 2015;13(2):305\u201318.","journal-title":"Mol cancer Research: MCR"},{"issue":"14","key":"3435_CR53","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"R SB","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"key":"3435_CR54","doi-asserted-by":"crossref","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X. Role of mitochondria in ferroptosis. Mol Cell 2019; 73(2):354\u201363.e3.","DOI":"10.1016\/j.molcel.2018.10.042"},{"issue":"2","key":"3435_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298\u2013308.","journal-title":"Mol Cell"},{"issue":"11","key":"3435_CR56","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00109-022-02257-5","volume":"100","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li Y, Du C, Kuang S, Zhou X, Zhang J, Ao X. Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression. J Mol Med. 2022;100(11):1539\u201356.","journal-title":"J Mol Med"},{"issue":"7998","key":"3435_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-023-06983-9","volume":"626","author":"Y Li","year":"2024","unstructured":"Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L, Wang C, Zhu Z, Chen X, Weng L, et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024;626(7998):411\u20138.","journal-title":"Nature"},{"issue":"7998","key":"3435_CR58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas FP, Alborzinia H, Santos AFD, Nepachalovich P, Pedrera L, Zilka O, Inague A, Klein C, Aroua N, Kaushal K, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626(7998):401\u201310.","journal-title":"Nature"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03435-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03435-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03435-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:03:01Z","timestamp":1750219381000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03435-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3435"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03435-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"type":"electronic","value":"1756-9966"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies have been approved by the Institutional Research Board, Shandong Provincial Hospital Affiliated to Shandong First Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}